Jan 12, 2026
Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
Jan 8, 2026
FineHeart secures €83 million to support its growth and establish itself as a future European leader in Active Implantable Medical Devices (AIMDs)
Jan 8, 2026
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
Jan 6, 2026
Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation
Oct 28, 2025